Valsartan, Losartan and Irbesartan use in the USA, UK, Canada and Denmark after the nitrosamine recalls: a descriptive cohort study

OBJECTIVES: To examine valsartan, losartan and irbesartan usage and switching patterns in the USA, UK, Canada and Denmark before and after July 2018, when the first Angiotensin-Receptor-Blocker (ARB) (valsartan) was recalled. DESIGN: Retrospective cohort study. SETTING: USA, Canadian administrative...

Descripción completa

Detalles Bibliográficos
Autores principales: Eworuke, Efe, Shinde, Mayura, Hou, Laura, Paterson, Michael J, Jensen, Peter Bjødstrup, Maro, Judith C, Rai, Ashish, Scarnecchia, Daniel, Pennap, Dinci, Woronow, Daniel, Ghosh, Rebecca E, Welburn, Stephen, Pottegard, Anton, Platt, Robert W, Lee, Hana, Bradley, Marie C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111915/
https://www.ncbi.nlm.nih.gov/pubmed/37068898
http://dx.doi.org/10.1136/bmjopen-2022-070985

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111915/
https://www.ncbi.nlm.nih.gov/pubmed/37068898
http://dx.doi.org/10.1136/bmjopen-2022-070985

Ejemplares similares